Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
1,1 USD | 0,00 % | -0,90 % | -1,79 % |
Resumen de negocios
Número de empleados: 100
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Novel Immunotherapies
100,0
%
| 6 | 100,0 % | 8 | 100,0 % | +37,48 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 6 | 100,0 % | 8 | 100,0 % | +37,48 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 69 | 01/07/19 | |
William Quinn
DFI | Director of Finance/CFO | 53 | 01/05/20 |
John Tomaro
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/20 |
Edith Perez
CTO | Chief Tech/Sci/R&D Officer | 67 | 01/04/20 |
Priti Hegde
CTO | Chief Tech/Sci/R&D Officer | 52 | - |
Karen L. Bergman
IRC | Investor Relations Contact | - | - |
Sarah Nemec
PRN | Corporate Officer/Principal | - | 01/01/20 |
Yu Tai
LAW | General Counsel | - | - |
Wesley Burwell
HRO | Human Resources Officer | - | 01/01/21 |
Grant Yonehiro
PRN | Corporate Officer/Principal | 60 | 01/11/16 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Richard Miller
BRD | Director/Board Member | 73 | 01/07/17 |
Mahendra Shah
BRD | Director/Board Member | 79 | 01/09/16 |
James Healy
BRD | Director/Board Member | 58 | 01/01/21 |
Kathy LaPorte
BRD | Director/Board Member | 62 | 01/12/20 |
Edgar Engleman
FOU | Founder | 78 | 22/01/15 |
Nicole Onetto
BRD | Director/Board Member | 71 | 14/12/21 |
Director/Board Member | 54 | 17/11/21 | |
Chief Executive Officer | 69 | 01/07/19 | |
Frank Lee
BRD | Director/Board Member | 56 | 17/11/21 |
Laura Berner
BRD | Director/Board Member | 49 | 14/12/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 38 127 740 | 36 624 368 ( 96,06 %) | 0 | 96,06 % |
Información de la empresa
Bolt Biotherapeutics, Inc.
900 Chesapeake Drive
94063, Redwood City
+650 665 9295
http://www.boltbio.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-1,79 % | 41,94 M | |
+8,96 % | 105 mil M | |
-1,43 % | 104 mil M | |
+4,40 % | 22,94 mil M | |
-12,15 % | 22,34 mil M | |
-4,36 % | 19,25 mil M | |
-39,98 % | 17,08 mil M | |
-10,04 % | 16,96 mil M | |
+38,61 % | 12,63 mil M | |
+313,59 % | 8487,34 M |
- Bolsa de valores
- Acciones
- Acción BOLT
- Empresa Bolt Biotherapeutics, Inc.